Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-5515 (Circulan) for chronic fatigue due to impaired circulation
NCT03542721Phase 4Unknown
- Sponsor
- Dong-A Pharmaceutical
- Start
- Jan 2018
- Primary completion
- Jun 2019
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS) comparing DA-5515 Capsule with Placebo (2 arms). Primary endpoint: Checklist Individual Strength at 8 weeks. Status: unknown.
02
Drugs
DA-5515
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT03542721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542721.